Jan Endrikat

ORCID: 0000-0001-6063-5014 · 7 papers in corpus
review 2026
Recent Developments and Future Perspectives in Magnetic Resonance Imaging and Computed Tomography Contrast Media
Investigative radiology ·doi:10.1097/rli.0000000000001180

This review provides a comprehensive analysis of recent advancements in computed tomography (CT) and magnetic resonance imaging (MRI) contrast media, offering a critical evaluation of current trends and exploring future directions in the fi…

other 2017
Letter to the editor in response to "Minimal clinically important difference for pain on the VAS scale and the relation to quality of life in women with endometriosis" by Wickström and Edelstam
Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives ·doi:10.1016/j.srhc.2017.10.004
meta-analysis 2011
Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide
Contraception ·doi:10.1016/j.contraception.2011.04.009

BACKGROUND: The objective of this analysis was to provide a comprehensive review of ovulation inhibition data of progestins currently available worldwide. This analysis may serve as a reference tool for research on new progestin molecules. …

other 2009
Pattern recognition in menstrual bleeding diaries by statistical cluster analysis
BMC women's health ·doi:10.1186/1472-6874-9-21

BACKGROUND: The aim of this paper is to empirically identify a treatment-independent statistical method to describe clinically relevant bleeding patterns by using bleeding diaries of clinical studies on various sex hormone containing drugs.…

rct 2008
Original research article Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies ☆,☆☆

Background: Attempts to improve the tolerability of combined oral contraceptives (COCs) have included the substitution of ethinylestradiol (EE) with 17β-estradiol (E2). However, this has proved unsatisfactory, specifically in terms of cycle…

rct 2007
A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women
Maturitas ·doi:10.1016/j.maturitas.2007.08.004

OBJECTIVES: To evaluate the effects of an estrogen-reduced, continuous-combined hormone therapy preparation (HT) containing 1mg estradiol valerate (1EV) and 2mg dienogest (2DNG) on the number of moderate and severe hot flushes. METHODS: Th…

rct 2007
A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625180701441030

OBJECTIVES: To evaluate the impact of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate (1EV) and 2 mg dienogest (2DNG) on metabolism. METHODS: In a randomized double-blin…